Editorial Commentary: The Trials and Tribulations of Treating Clostridium difficile Infection--One Step Backward, One Step Forward, but Still Progress
Author:
- 5 May 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 59 (3) , 355-357
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypesJournal of Antimicrobial Chemotherapy, 2012
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infection Control & Hospital Epidemiology, 2010
- Emergence of reduced susceptibility to metronidazole in Clostridium difficileJournal of Antimicrobial Chemotherapy, 2008
- Comparison of Clinical and Microbiological Response to Treatment ofClostridium difficile–Associated Disease with Metronidazole and VancomycinClinical Infectious Diseases, 2008
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated DiarrheaClinical Infectious Diseases, 2006
- Metronidazole for Clostridium difficile-Associated Disease: Is It Okay for Mom?Clinical Infectious Diseases, 2005
- Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycinJournal of Antimicrobial Chemotherapy, 1995
- Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficileJournal of Antimicrobial Chemotherapy, 1989
- Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.Gut, 1986